SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features

Bibliographic Details
Main Authors:	Clifford, R, Ackroyd, S, Burns, A, Timbs, A, Maelfait, J, Dreau, H, Henderson, S, Ross, M, Bentley, D, Hillmen, P, Knight, S, Taylor, J, Hatton, C, Rehwinkel, J, Crow, Y, Schuh, A
Format:	Conference item
Published:	2012

Similar Items

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
by: Clifford, R, et al.
Published: (2014)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
by: Burns, A, et al.
Published: (2012)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
by: Burns, A, et al.
Published: (2012)

Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1
by: Maelfait, J, et al.
Published: (2016)

SAMHD1-dependent retroviral control and escape in mice.
by: Rehwinkel, J, et al.
Published: (2013)

SAMHD1-dependent retroviral control and escape in mice
by: Rehwinkel, J, et al.
Published: (2013)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1
by: Jonathan Maelfait, et al.
Published: (2016-08-01)

PNP inhibitors selectively kill cancer cells lacking SAMHD1
by: Tamara Davenne, et al.
Published: (2020-11-01)

Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
by: Haywood, A, et al.
Published: (2010)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
by: Burns, A, et al.
Published: (2017)

Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
by: Klintman, J, et al.
Published: (2018)

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors
by: Timbs, A, et al.
Published: (2010)

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B Cell Transcription Factors
by: Timbs, A, et al.
Published: (2010)

RECONsidering sensing of cyclic dinucleotides
by: Maelfait, J, et al.
Published: (2017)

Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
by: Gallienne, A, et al.
Published: (2009)

Exploring tumour suppressor ATRX and telomere maintenance in MLLr leukaemia
by: Gracias, D
Published: (2018)

Nine Novel Mutations in the Erythroid Transcription Factor KLF1 Gene Associated with Increased Fetal Hemoglobin Levels in Adults
by: Gallienne, A, et al.
Published: (2011)

Substrates and Inhibitors of SAMHD1.
by: Joseph A Hollenbaugh, et al.
Published: (2017-01-01)

Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
by: Buchanan, J, et al.
Published: (2017)

Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.
by: Knight, S, et al.
Published: (2009)

Keeping your armour intact: How HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS Prospects and Overviews J. Maelfait et al.
by: Maelfait, J, et al.
Published: (2014)

Nucleic acid sensors and programmed cell death
by: Maelfait, J, et al.
Published: (2019)

Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.
by: Maelfait, J, et al.
Published: (2014)

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
by: Chowdhury, O, et al.
Published: (2011)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
by: Wing, P, et al.
Published: (2019)

SAMHD1 Functions and Human Diseases
by: Si’Ana A. Coggins, et al.
Published: (2020-03-01)

EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
by: Jianyuan Zeng, et al.
Published: (2022-12-01)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
by: Oscier, D, et al.
Published: (2012)

MicroRNA expression in chronic lymphocytic leukaemia.
by: Lawrie, C, et al.
Published: (2009)

A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
by: Mlcochova, P, et al.
Published: (2017)

SAMHD1 … and Viral Ways around It
by: Janina Deutschmann, et al.
Published: (2021-03-01)

Characterisation of SAMHD1's ancestral function
by: Davenne, T
Published: (2018)

<it>Thrombospondin-4 </it>is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation
by: Greco Sonia A, et al.
Published: (2010-09-01)

P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTARABINE-BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT-AML TRIAL
by: M. Jädersten, et al.
Published: (2022-06-01)

Structure of putative tumor suppressor ALDH1L1
by: Yaroslav Tsybovsky, et al.
Published: (2022-01-01)

P1304: THE NOVEL TUMOR SUPPRESSOR SAMHD1 CONTRIBUTES TO ANTI-TUMOR RESPONSES IN A CGAS-STING-DEPENDENT OR INDEPENDENT PATHWAY IN HODGKIN LYMPHOMA (HL)
by: I. Xagoraris, et al.
Published: (2022-06-01)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
by: Hiroaki Iwasa, et al.
Published: (2015-12-01)